0001144204-16-080445.txt : 20160210 0001144204-16-080445.hdr.sgml : 20160210 20160210174459 ACCESSION NUMBER: 0001144204-16-080445 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160209 FILED AS OF DATE: 20160210 DATE AS OF CHANGE: 20160210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp. CENTRAL INDEX KEY: 0001430306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261434750 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 509 MADISON AVE. - SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 1-800-849-7894 MAIL ADDRESS: STREET 1: 509 MADISON AVE. - SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC. DATE OF NAME CHANGE: 20080320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANDRY DONALD W CENTRAL INDEX KEY: 0001563616 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36019 FILM NUMBER: 161406923 MAIL ADDRESS: STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP STREET 2: 509 MADISON AVE., STE 306 CITY: NEW YORK STATE: NY ZIP: 10022 4 1 v431271_4.xml OWNERSHIP DOCUMENT X0306 4 2016-02-09 0 0001430306 Tonix Pharmaceuticals Holding Corp. TNXP 0001563616 LANDRY DONALD W C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., STE 306 NEW YORK NY 10022 1 0 0 0 Restricted Stock Unit 2016-02-09 4 A 0 7500 0.00 A Common Stock 7500 7500 D Each restricted stock unit represents the right to receive, at settlement, one share of common stock. These restricted stock units are scheduled to vest 100% on February 9, 2017. The restricted stock units were granted pursuant to the Issuer's 2014 Stock Incentive Plan. /s/Jessica Morris, Attorney-in-Fact 2016-02-10